Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Investigation of Adjuvant Combined Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

NCT02641093 is registered in ClinicalTrials.gov with Trisha Wise-Draper as lead sponsor.

NCT NCT02641093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02641093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Investigation of Adjuvant Combined Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Lead sponsor
Trisha Wise-Draper
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 31, 2016
Completion date
November 2, 2026
Enrollment
96 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer